Aytu BioPharma Inc (NAS:AYTU)
$ 1.85 -0.06 (-3.14%) Market Cap: 11.38 Mil Enterprise Value: 6.87 Mil PE Ratio: 0 PB Ratio: 0.40 GF Score: 31/100

Aytu BioScience Inc COVID-19 Initiatives Update Call Transcript

Apr 21, 2020 / 08:30PM GMT
Release Date Price: $272 (-2.16%)
Operator

Good afternoon, and thank you for joining us today for the Aytu BioScience COVID-19 Initiatives Update Call. With me this afternoon is Aytu's Chairman and Chief Executive Officer, Josh Disbrow.

I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone number and conference ID provided in the press release form from Monday, April 20, 2020. In addition, a webcast will be accessible live and archived on Aytu's website within the Investors section under Events & Presentations at aytubio.com.

Finally, I'd also like to call your attention to the customary safe harbor disclosure regarding forward-looking statements. The conference call today will contain forward-looking statements including statements regarding the goals, strategies, beliefs, expectations and future potential of operating results of Aytu BioScience. Although management believes these statements are reasonable based on estimates and assumptions as of today, April 21, 2020, these statements are not guarantees of future performance. Time-sensitive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot